The experience from a leading pharma company in the ICIQ-Joint Units: “I was impressed by the level of our discussions on Medicinal Chemistry”
Licensing opportunities and spin-off companies to scale up ICIQ technologies to companies
CRYSFORMA: Polymorphism and crystallization, key issues in drug development according to international health security
The Characterization Technologies Department will invest almost 3M € in state-of-the-art equipment in 2023
ICIQ’s Bio-Based Polymer Platform: creating innovative materials from organic waste and CO2
The ICIQ-Energy Lab: a lab originally designed to analyse CO2 reduction products that offers much more
CRYSFORMA, your partner in solid state development
TAC12 records a TV report about Jolt Solutions, a spin-off from the ICIQ
CSOL: closing the gap between ICIQ’s discoveries and industry
ICIQ-Joint Units: the best strategy to be at the state of the art in R&D
ICIQ offers its services at the online marketplace Scientist.com
ICIQ will have first ED electron diffractometer installed in 2023
ICIQ promotes a new lab dedicated to analysing the products of CO2 reduction: the Energy Lab
ICIQ’s third spin-off, Jolt, has the secret formula for hydrogen production
A collaboration between Applus+ IDIADA and ICIQ studies the gases derived from the combustion of car batteries
Plataforma de Polímeros Bio-basados del ICIQ: de residuos agroalimentarios a pinturas, recubrimientos, adhesivos y materiales composite
ICIQ’s Bio-Based Polymer Platform: From Agrofood Waste to Paints, Coatings, Adhesives and Lightweight Composites
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 7
- Next Page »